Form 4: Cibus Inc. Executive Sells 2,000 Shares of Common Stock
SEC Form 4 Filing
Gregory Francis William Gocal, Chief Scientific Officer & EVP of Cibus, Inc., sold 2,000 shares of Class A Common Stock on June 27, 2024, at a price of $10 per share, according to a Form 4 filing.
Summary
- Gregory Francis William Gocal, the Chief Scientific Officer & EVP of Cibus, Inc., sold 2,000 shares of Class A Common Stock on June 27, 2024.
- The shares were sold at a price of $10 per share.
- The transaction was executed automatically under a pre-arranged Rule 10b5-1 trading plan adopted on March 27, 2024.
- Following the sale, Gocal directly owns 318,844 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of an insider stock sale under a pre-existing trading plan.
Industry Context
This is a routine disclosure of an insider stock sale. It's common for executives to have pre-arranged trading plans (Rule 10b5-1) to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date the reporting person adopted a Rule 10b5-1 trading plan |
| 06/27/2024 | Date of the stock sale transaction |
| 07/15/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.